Cefoxitin
Back to searchMolecule Structure
Scientific Name
Cefoxitin
Description of the Drug
Cefoxitin is a semi-synthetic, broad-spectrum antibiotic for parenteral administration used for the treatment of serious bacterial infections, such as urinary tract infection, blood infection, bone and joint infection, and lower respiratory tract infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01331
http://www.drugbank.ca/drugs/DB01331
Brand Name(s)
Cenomycin, Mefoxin, Mefoxitin
Company Owner(s)
Samson Medical Technologies Llc, Fresenius Kabi Usa Llc, Hospira Inc, Hikma Farmaceutica (Portugal) Sa, Merck And Co Inc, B Braun Medical Inc, Acs Dobfar Spa, Hikma Pharmaceuticals Usa Inc, Mylan Institutional Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL15971 | ||
PharmGKB | PA448856 | ||
Human Metabolome Database | HMDB0015426 | ||
DrugBank | DB01331 | ||
PubChem: Thomson Pharma | 14929780 | 15501432 | |
PubChem | 441199 | ||
LINCS | LSM-5786 | ||
Nikkaji | J17.441F | ||
PDBe | CFX | ||
BindingDB | 50335563 | ||
EPA CompTox Dashboard | DTXSID1022764 | ||
DrugCentral | 550 | ||
Brenda | 879 | ||
ChemicalBook | CB9490581 | ||
Guide to Pharmacology | 10937 | ||
rxnorm | MEFOXIN | CEFOXITIN SODIUM | CEFOXITIN |
PubChem: Drugs of the Future | 12012592 | ||
KEGG Ligand | C06887 | ||
ChEBI | 209807 | ||
ZINC | ZINC000003830449 |